Understanding Stent Deformation

Slides:



Advertisements
Similar presentations
PCI Unmet Clinical Needs
Advertisements

Bifurcation coronary stenting: State 0f the Art Mazhar M Khan Consultant Cardiologist Royal Victoria Hospital Belfast, N.Ireland.
Four Drug Eluting Stent Trials Keith D Dawkins MD FRCP FACC Southampton University Hospital Keith D Dawkins MD FRCP FACC Southampton University Hospital.
W e m a k e i d e a s c o m e a l i v e 001IHP For internal use only Not only a peripheral stent available in Renal sizes...
Optimal Stent Expansion and Optimization
2 Introduction Drug-eluting stents have defined a new era in the successful treatment of coronary artery disease However, like any therapy, DES results.
As presented by Patrick W. Serruys, MD, PhD, FACC Principal Investigator Thoraxcentre - Erasmus University Rotterdam, The Netherlands PISCES Paclitaxel.
5F in 6F (7F) technique in DES era (Parent-child catheter technique)
1 *Report IIB(R) 27/ The CoStar Stent (Conor) was also tested but is not shown in this report as it only presents the commercially available stents.
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Keith Dawkins MD FRCP FACC FSCAI Chief Medical Officer Senior Vice President Boston Scientific Corporation Why Boston Scientific Persists with the Two-Drug.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
The First Affiliated Hospital of Harbin Medical University
Featuring Bifurcation Trans-Radial Approach Technical Issues Martial Hamon Caen, France Provisionnal T stenting With the Frontier stent Main Branch Balloon.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Retrograde Techniques and the Impact of Operator.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Kissing Balloon or Sequential Dilation of the Side.
Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Post-Approval.
Real-world clinical experience with an everolimus eluting platinum chromium stent with an abluminal biodegradable polymer – a report from the Swedish Coronary.
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
The OPTIMAX first-in-man study Mid-term clinical outcome of Titanium-Nitride-Oxide-coated Cobalt Chromium stents in patients with de novo coronary artery.
Mercy Angiography Unit, Auckland New Zealand
Longitudinal Compression Second Generation DES: What You Need to Know
Boston Scientific Corporation: DES Bioabsorbable Technologies
William A. Gray, MD DISCLOSURES Consulting Fees
Ospedale San Raffaele, Milan, Italy
Regulatory Challenges for Bioabsorbable Stent Approval
Hina M. Pinto, MSE Scientific Reviewer
Bifurcation Balloon & Stent Delivery System
Lutonix® Paclitaxel-Coated Balloon to Treat Obstructive Lesions in the Superficial Femoral and Popliteal Arteries Preliminary Six-Month Results from.
IVUS, FFR, OCT- Which Should I Use For PCI?
Abbott Vascular Bifurcation Program
Three-year results from the multicentre PROMUS Element European Post-Approval (PE-Prove) Registry: outcomes in 1010 unselected patients treated with a.
Clinical Usefulness of Post-Stenting FFR
Why I Don’t Believe in BRS as the Future Scaffold Technology
Guideliner related stent stripping
(DES)+BVS +DCB for long diffuse LAD disease
How to Handle a Complex Bifurcation Lesion
A Novel “Stent-On-A-Wire”Ultra Low Profile Stent Delivery System
CRT Washington, D.C. February 23, 2010 Tim A. Fischell, M.D. FACC
Crossing SFA-Popliteal Artery CTO’s
Summary and Conclusion
A Fixed Guidewire Stent Delivery System
Medical Device Evaluation Division,
ABSORB Japan: 3-year Clinical and Angiographic Results of a Randomized trial Evaluating the Absorb Bioresorbable Vascular Scaffold vs. Metallic Drug-eluting.
The Tryton Bifurcation Trial:
DES Bioabsorbable and DCB Technologies
BRS Summit – Scaffold Fractures
BVS Expand: First Results of Wide Clinical Applications
The XIENCE V EXCEED Study
Subintimal Tracking and Reentry for CTO STAR Method
Recanilization of Central Venous Total Occlusions
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
EVERBIO II Trial design: Patients with CAD were randomized in a 1:1:1 fashion to either Absorb BVS, Biomatrix Flex stent [BES], or Promus Element EES.
3-Year Clinical Outcomes From the RESOLUTE US Study
ENDEAVOR IV: 5 Year Final Outcomes
ZEUS Trial design: Patients who were deemed uncertain DES candidates due to bleeding, thrombotic, or restenosis risk were randomized to receive either.
Bifurcation Disease: Simulation Training Curriculum
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
ENDEAVOR II Five-Year Clinical Follow-up
Gregg W. Stone, MD Columbia University Medical Center
ENDEAVOR III Multicenter Randomized Trial Clinical/MACE Angio/IVUS
Updated 3-Year Meta-Analysis of the TAXUS Clinical Trials Safety and Efficacy Demonstrated in 3,445 Randomized Patients Time allocation for this talk.
Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J
Θεματική ενότητα: Stenting
Tanveer Rab et al. JCIN 2017;10:
Drug-eluting coronary stent market overview
Presentation transcript:

Understanding Stent Deformation AXIAL Understanding Stent Deformation Keith Dawkins MD FRCP FACC FSCAI Global Chief Medical Officer Senior Vice President Boston Scientific Corporation

Keith D. Dawkins, MD Salary: Boston Scientific Corporation Ownership Interest (Stocks, Stock Options, or other Ownership Interest):

Stent Deformation: Initial Observations

Stent Deformation: Endeavor/Driver 7-Crown Stents Pitney M: EuroIntervention 2011;7:256-262

Stent Deformation: Endeavor/Driver 7-Crown Stents Outcomes in Patients Demonstrating Stent Deformation EVENT N % Angiographic Success 13/14 93% Re-Stent Required 9/14 64% AMI (Tn >1.0) 7/14 50% Stent Thrombosis 0% Early Restenosis 2 14% Usual Restenosis Total Restenosis 4 29% 30-Day MACE 3 21% 6-Month MACE 5 36% 1000 patient, prospective, single-center registry of 2.25-2.75mm Endeavor/Micro-Driver stents Pitney M: EuroIntervention 2011;7:256-262

Hanratty CG: EuroIntervention 2011;7:872-877

Longitudinal Compression Manuscript Three cases of Longitudinal Compression (ELEMENT, RESOLUTE INTEGRITY, BIOMATRIX) ‘In this particular case [Promus Element] the stent at the ostium of the vessel was crushed longitudinally as an Amplatz 1 guide catheter was advanced into the vessel to provide improved guide support. We did not feel this issue was related to the stent platform itself, as a braided guide catheter is capable of deforming any coronary stent’ ‘In this case, the enhanced radiographic visibility of this platform [Element] meant that the complication was immediately apparent’ ‘However we have since observed this phenomenon within our institution with all modern DES platforms from each of the major manufacturers’ Hanratty CG: EuroIntervention 2011;7:872-877

What is Longitudinal Stent Deformation? Longitudinal stent deformation is the axial shortening or lengthening of a stent after implantation, resulting from interaction with an ancillary device such as a guide catheter, post-dilatation balloon, or IVUS catheter AXIAL

Longitudinal Stent Deformation Described with Eight Stent Types Stent Name Material Strut Thickness Connectors BioMATRIX Stainless Steel 112µm 2 or 3  Endeavor Cobalt chromium (MP35N) 91µm 2 or 3 Micro Driver PROMUS Element Platinum chromium 81µm (86µm for ≥4mm diam) 2 Resolute Integrity 1, 2 or 3 TAXUS Element TAXUS Liberté 316L Stainless Steel 97µm 3 Xience V (L605)

Longitudinal Stent Deformation Created in a Model with Malapposed Struts

Ormiston JA: J Am Coll Cardiol Intv 2011;4:1310 –1317

Are these Bench Tests relevant? Ormiston JA: J Am Coll Cardiol Intv 2011;4:1310 –1317

Longitudinal Strength In Perspective Is 0.5 Newtons Relevant? Significant forces can be generated using normal procedural techniques Force (Newtons) 0.5N Embolize a stent Kink a Hypotube Deep-seat a Guide Catheter Catheter tip crossing a deployed stent

Clinically Relevant Stent Compression Test Ormiston Test Relevant Test? Internal Stent supported with a pipe Constrained at base Force applied 360O to full diameter of stent Force value of 1N Constrained by vessel Open ended Malapposed tapered section Point force applied to stent With a 1N load is there a clinical difference in procedural outcome?

16mm WH ELEMENT 16mm WH XIENCE V Pre Post Post Pre

Prabhu S: EuroInterv 2011; published ahead of print

Is the ELEMENT Platform associated with a high rate of MACE Events? PERSEUS Trial PLATINUM Trial MACE (%) 1-year N=320 N=942 N=762 N=768 TAXUS Express TAXUS Element* PROMUS PROMUS Element *ION Kereiakes DJ: J Am Coll Cardiol 2010;56:264-271 Stone GW; J Am Coll Cardiol 2011; 57:1700-1708.

Longitudinal stent deformation: QCA analysis from the PERSEUS & PLATINUM Trials Kereiakes DJ: EuroInterv 2012 (in press)

Platform Innovation Leads to Lower Complaint Rates Improvement in Stent Material & Design  65% Lower Complaint Rate 1.00 Normalized Complaint Rate TAXUS Express TAXUS Liberté PROMUS ELEMENT

PROMUS Element in SCAAR Sarno G: Int J Cardiol 2012; doi.org/10.1016/j.ijcard.2011.12.057

PROMUS Element in SCAAR: Restenosis Follow-up (months) N=13,577 stents (PROMUS Element = 2,724) Sarno G: Int J Cardiol 2012; doi.org/10.1016/j.ijcard.2011.12.057

PROMUS Element in SCAAR: Stent Thrombosis Follow-up (months) N=13,577 stents (PROMUS Element = 2,724) Sarno G: Int J Cardiol 2012; doi.org/10.1016/j.ijcard.2011.12.057

Reducing Risk and Impact of Stent Deformation Similar DFU Verbiage Across Multiple Products Inflation Pressure and Time Care and Precaution Details 1. Care should be taken to control the position of the guide catheter tip during stent delivery, deployment and balloon withdrawal. 2. Care must be exercised when crossing a newly deployed stent with any wire, catheter or ancillary device to avoid disrupting the stent placement, apposition, geometry, and/or coating. Nominal: 11ATM Maintain inflation pressure for 15-30 seconds for full expansion of the stent ION™ Stent 1. Care should be exercised when crossing a newly deployed stent with an intravascular ultrasound (IVUS) catheter, a coronary guidewire, or balloon catheter to avoid disrupting the stent placement, apposition, geometry, and/or coating. 2. …a larger balloon may be used to expand the stent further… If this is required, the stented segment should be recrossed carefully with a prolapsed guidewire to avoid dislodging the stent. Nominal: 9ATM Maintain inflation pressure for 15-30 seconds for full expansion of the stent Endeavor® Stent 1. Care should be taken to control the guiding catheter tip during stent delivery, deployment, and balloon withdrawal. 2. When crossing a newly deployed stent with an intravascular ultrasound (IVUS) catheter, a coronary guide wire, a balloon catheter or delivery system, exercise care to avoid disrupting the stent placement, apposition, geometry, and/or coating. 3. The stent may be further expanded... the stented segment should be recrossed carefully with a prolapsed guide wire to avoid dislodging the stent. Nominal: 8ATM for 2.5 and 2.75mm 9ATM for 3.0, 3.5, 4.0mm’s Maintain pressure for 30 seconds Xience V® (PROMUS®) Stent All verbiage copied directly from U.S. Instructions for Use

Conclusions: Stent Deformation occurs rarely Deformation is not unique to a particular stent: it has been described with 8 stent types In vitro mechanical testing is of questionable relevance to clinical practice Understanding the phenomenon, in particular avoiding the interaction between the stent and ancillary devices, is key Adequately prepare the lesion Initial stent implant at high pressure (≥ 12 atm) Avoid guide-wire bias Care with IVUS crossing Wait for full balloon deflation (NB: Long balloons)